Boston Scientific Corp. (BSX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Boston Scientific Corp. (BSX)
Go deeper and ask any question about BSX
Company Performance
Current Price
as of Sep 13, 2024$83.31
P/E Ratio
67.40
Market Cap
$122.68B
Description
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Metrics
Overview
- HQMarlborough, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerBSX
- Price$83.31-0.62%
Trading Information
- Market Cap$122.68B
- Float99.57%
- Average Daily Volume (1m)4,410,758
- Average Daily Volume (3m)5,557,706
- EPS$1.25
Company
- Revenue$15.23B
- Rev Growth (1yr)14.48%
- Net Income$324.00M
- Gross Margin62.74%
- EBITDA Margin25.68%
- EBITDA$1.06B
- EV$122.48B
- EV/Revenue8.04
- P/E67.40
- P/S8.12
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset